David A. Stoltz, MD, PhD
Professor
Biography
Dr. Stoltz is Director of the CFF RDP and an NIH PPG studying the pathogenesis of CF lung disease in CF pig models. His areas of research include the roles of CFTR in smooth muscle, and CF disease pathogenesis involving goblet cell functions, innate immunity, and inflammation. Recently, Dr. Stoltz developed in vitro organoid models of the gallbladder from CF pigs, ferrets, and humans, which his group uses to study how CFTR function influences pH regulation and mucin secretion in this organ.
NIH R38 HL150208 | Iowa StARR Scholars Program |
NIH T32 HL166134 | Climate Change & Lung Health Training Program |
U of Washington (CFF) UWSC13787 | Clinical, Microbiologic, & Immune Responses to Trikafta |
NIH P01 HL152960 | PPG: Molecular Therapies for Cystic Fibrosis Lung Disease – Animal Core C: Models Core |
NIH R01 H163556 | Testing the Contributions of Airway Submucosal Glands & Surface Epithelia to Lung Health |
